Paloma Partners’s Fibrocell Science Inc. FCSC Stock Holding History

Paloma Partners’s Portfolio FCSC Stock Details FCSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-6,450	Closed	-$111K	–	2268
2016 Q2	$111K	Buy	+6,450	New	+$201K	﹤0.01%	2068
2016 Q1	–	Sell	-906	Closed	-$62K	–	2161
2015 Q4	$62K	Buy	+906	New	+$65.1K	﹤0.01%	1628
2014 Q3	–	Sell	-6,396	Closed	-$383K	–	1427
2014 Q2	$383K	Buy	+6,396	New	+$357K	0.02%	711

Other funds holding FCSC

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HVC

Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Paloma Partners's FCSC Position: Q3 2016 in Review

Paloma Partners sold out of Fibrocell Science Inc. (FCSC) in Q3 2016, closing a stake of 6,450 shares — an estimated $111K sold.

Paloma Partners first reported a position in FCSC in Q2 2014 and held it in 3 quarters. The position peaked at $383K in Q2 2014. 37 funds tracked by Wall St. Rank hold FCSC as of Q3 2016.

Paloma Partners reported no remaining Fibrocell Science Inc. position as of Q3 2016 after selling out during the quarter.
Paloma Partners sold 6,450 Fibrocell Science Inc. shares in Q3 2016, an estimated $111K.
Paloma Partners first reported a position in Fibrocell Science Inc. in Q2 2014 and held it in 3 quarters.
Paloma Partners's Fibrocell Science Inc. position peaked at $383K in Q2 2014.
37 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q3 2016.

Based on Paloma Partners's 13F filing for Q3 2016, filed 14 Nov 2016.